BRCA1 targets G2/M cell cycle proteins for ubiquitination and proteasomal degradation

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Oncogene

• Publication date

  2013-10-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/onc.2012.522PMID 23246971PMCID PMC3796024
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BRCA1-dependent Chk1 phosphorylation triggers partial chromatin disassociation of phosphorylated Chk1 and facilitates S-phase cell cycle arrest.

  2012cited by this paper
• The BRCA1 ubiquitin ligase and homologous recombination repair

  2011cited by this paper
• BRCA1 Tumor Suppression Depends on BRCT Phosphoprotein Binding, But Not Its E3 Ligase Activity

  2011cited by this paper
• BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters.

  2011cited by this paper
• BRCA1 tumor suppression occurs via heterochromatin mediated silencing

  2011cited by this paper
• The UBXN1 Protein Associates with Autoubiquitinated Forms of the BRCA1 Tumor Suppressor and Inhibits Its Enzymatic Function

  2010cited by this paper
• BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha.

  2010cited by this paper
• The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress

  2009cited by this paper
• E3 ligase activity of BRCA1 is not essential for mammalian cell viability or homology-directed repair of double-strand DNA breaks

  2008cited by this paper
• The ubiquitin E3 ligase activity of BRCA1 and its biological functions

  2008cited by this paper
• CCDC98 is a BRCA1-BRCT domain–binding protein involved in the DNA damage response

  2007cited by this paper
• E2–BRCA1 RING interactions dictate synthesis of mono- or specific polyubiquitin chain linkages

  2007cited by this paper
• Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities

  2007cited by this paper
• Estrogen receptor α is a putative substrate for the BRCA1 ubiquitin ligase

  2007cited by this paper
• BRCA1 ubiquitinates RPB8 in response to DNA damage.

  2007cited by this paper
• Estrogen receptor alpha is a putative substrate for the BRCA1 ubiquitin ligase.

  2007cited by this paper
• A mechanism for transcriptional repression dependent on the BRCA1 E3 ubiquitin ligase

  2007cited by this paper
• RAP80 Targets BRCA1 to Specific Ubiquitin Structures at DNA Damage Sites

  2007cited by this paper
• Abraxas and RAP80 Form a BRCA1 Protein Complex Required for the DNA Damage Response

  2007cited by this paper
• Prevention of Brca1-Mediated Mammary Tumorigenesis in Mice by a Progesterone Antagonist

  2006cited by this paper
• The anaphase-promoting complex/cyclosome: APC/C

  2006cited by this paper
• BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP.

  2006cited by this paper
• Quantitative analysis of in vitro ubiquitinated cyclin B1 reveals complex chain topology

  2006cited by this paper
• BRCA1 at the crossroad of multiple cellular pathways: approaches for therapeutic interventions

  2006cited by this paper
• BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation

  2005cited by this paper
• Parkin Mediates Nonclassical, Proteasomal-Independent Ubiquitination of Synphilin-1: Implications for Lewy Body Formation

  2005cited by this paper
• Mad2 is required for inhibiting securin and cyclin B degradation following spindle depolymerisation in meiosis I mouse oocytes.

  2005cited by this paper
• The BRCA1 RING and BRCT Domains Cooperate in Targeting BRCA1 to Ionizing Radiation-induced Nuclear Foci*

  2005cited by this paper
• BRCA1/BARD1 Ubiquitinate Phosphorylated RNA Polymerase II*

  2005cited by this paper
• Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers

  2005cited by this paper
• Nucleophosmin/B23 Is a Candidate Substrate for the BRCA1-BARD1 Ubiquitin Ligase*

  2004cited by this paper
• A requirement for breast-cancer-associated gene 1 (BRCA1) in the spindle checkpoint.

  2004cited by this paper
• BRCA1-dependent ubiquitination of gamma-tubulin regulates centrosome number.

  2004cited by this paper
• BRCA1-Dependent Ubiquitination of γ-Tubulin Regulates Centrosome Number

  2004cited by this paper
• DNA Damage-Induced Cell Cycle Checkpoint Control Requires CtIP, a Phosphorylation-Dependent Binding Partner of BRCA1 C-Terminal Domains

  2004cited by this paper
• Enhancement of BRCA1 E3 Ubiquitin Ligase Activity through Direct Interaction with the BARD1 Protein*

  2003cited by this paper
• The BRCA1/BARD1 Heterodimer Assembles Polyubiquitin Chains through an Unconventional Linkage Involving Lysine Residue K6 of Ubiquitin*

  2003cited by this paper
• The BRCT Domain Is a Phospho-Protein Binding Domain

  2003cited by this paper
• Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains

  2002cited by this paper
• Phosphorylation of serine 1387 in Brca1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation.

  2002cited by this paper
• Arsenite-induced Cdc25C degradation is through the KEN-box and ubiquitin–proteasome pathway

  2002cited by this paper
• BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage

  2002cited by this paper
• BRCA1-associated tumorigenesis: what have we learned from knockout mice?

  2001cited by this paper
• Cancer-predisposing mutations within the RING domain of BRCA1: Loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity

  2001cited by this paper
• BRCA1 Is a Selective Co-activator of 14-3-3ς Gene Transcription in Mouse Embryonic Stem Cells* 210

  2001cited by this paper
• BRCA1 is a selective co-activator of 14-3-3 sigma gene transcription in mouse embryonic stem cells.

  2001cited by this paper
• Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis

  2001cited by this paper
• The KEN box: an APC recognition signal distinct from the D box targeted by Cdh1.

  2000cited by this paper
• RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination.

  1999cited by this paper
• p53 regulates a G2 checkpoint through cyclin B1.

  1999cited by this paper
• Mechanisms and regulation of the degradation of cyclin B.

  1999cited by this paper
• BRCA1 interacts with components of the histone deacetylase complex.

  1999cited by this paper
• Nuclear export of cyclin B1 and its possible role in the DNA damage‐induced G2 checkpoint

  1998cited by this paper
• Nuclear Localization of Cyclin B1 Controls Mitotic Entry After DNA Damage

  1998cited by this paper
• The proteolysis of mitotic cyclins in mammalian cells persists from the end of mitosis until the onset of S phase.

  1996cited by this paper

• Aberrant accumulation of phosphorylated BRCA1 in brainstem-type and cortical-type Lewy bodies in Lewy body disease

  2025cites this paper
• Ubiquitin-Proteasome-Mediated Protein Degradation and Disorders of the Central Nervous System

  2025cites this paper
• BRCA1 and BRCA2 gene expression: p53- and cell cycle-dependent repression requires RB and DREAM

  2025cites this paper
• Developing a prognostic signature and characterizing the tumor microenvironment based on centrosome-related genes in lung adenocarcinoma

  2025cites this paper
• ReCorDE: a framework for identifying drug classes targeting shared vulnerabilities with applications to synergistic drug discovery

  2024cites this paper
• Bioinformatic Analyses and Integrated Machine Learning to Predict prognosis and therapeutic response Based on E3 Ligase-Related Genes in colon cancer

  2024cites this paper
• BRCA1 deficiency enhances the aggressiveness of breast cancer cells expressing HPV16 oncoproteins

  2024cites this paper
• Cellular mechanisms mediating the anti-cancer effects of carnosol on gingiva carcinoma

  2024cites this paper
• BRCA1 and BRCA2: from cancer susceptibility to synthetic lethality

  2024cites this paper
• Cockayne syndrome group A protein localizes at centrosomes during mitosis and regulates Cyclin B1 ubiquitination.

  2023cites this paper
• Arsenite Impairs BRCA1-Dependent DNA Double-Strand Break Repair, a Mechanism Potentially Contributing to Genomic Instability

  2023cites this paper
• Hypoxia-induced UBE2K promotes the malignant progression of HCC.

  2023cites this paper
• Identification of the c.829_832delAATA Deletion Variants in the BRCA1 Gene Associated with Hereditary Breast/Ovarian Cancer ˗ Case Report

  2022cites this paper
• A Novel Copper(II) Indenoisoquinoline Complex Inhibits Topoisomerase I, Induces G2 Phase Arrest, and Autophagy in Three Adenocarcinomas

  2022cites this paper
• Effects of Silver Nanoparticles and Silver Nitrate on mRNA and microRNA Expression in Human Hepatocellular Carcinoma Cells (HepG2).

  2021cites this paper
• Selenomethionine protects hematopoietic stem/progenitor cells against cobalt nanoparticles by stimulating antioxidant actions and DNA repair functions

  2021cites this paper
• Ixazomib inhibits myeloma cell proliferation by targeting UBE2K.

  2021cites this paper
• The BRCA1/BARD1 ubiquitin ligase and its substrates.

  2021cites this paper
• Regulation of PCTAIRE1 protein stability by AKT1, LKB1, and BRCA1.

  2021cites this paper
• New Germinal Mutation of BRCA1 gene (c.829_832delAATA) in a Polish Patient with Breast/Ovarian Cancer

  2020cites this paper
• Regulatory Mechanisms of Cell Polyploidy in Insects

  2020cites this paper
• Functional characterization of full-length BARD1 strengthens its role as a tumor suppressor in neuroblastoma

  2020cites this paper
• Expression of tripartite motif-containing 44 and its prognostic and clinicopathological value in human malignancies:a meta-analysis

  2020cites this paper
• De novo lipogenesis at the mitotic exit is used for nuclear envelope reassembly/expansion. Implications for combined chemotherapy

  2019cites this paper
• A Multidimensional Characterization of E3 Ubiquitin Ligase and Substrate Interaction Network

  2019cites this paper
• MiR-210-3p protects endometriotic cells from oxidative stress-induced cell cycle arrest by targeting BARD1

  2019cites this paper
• Aberrant Accumulation of BRCA1 in Alzheimer Disease and Other Tauopathies.

  2019cites this paper
• BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance

  2019cites this paper
• Regulating BRCA1 protein stability by cathepsin S-mediated ubiquitin degradation

  2018cites this paper
• BRCA1 through Its E3 Ligase Activity Regulates the Transcription Factor Oct1 and Carbohydrate Metabolism

  2018cites this paper
• JNK and Yorkie drive tumor progression by generating polyploid giant cells in Drosophila

  2018cites this paper
• Inhibiting homologous recombination decreases extrachromosomal amplification but has no effect on intrachromosomal amplification in methotrexate‐resistant colon cancer cells

  2018cites this paper
• PALB2 connects BRCA1 and BRCA2 in the G2/M checkpoint response

  2018cites this paper
• Cyclin B1 stability is increased by interaction with BRCA1, and its overexpression suppresses the progression of BRCA1-associated mammary tumors

  2018cites this paper
• BRCA 1 185 delAG tumors may acquire therapy resistance through expression of RINGless BRCA 1

  2018cites this paper
• Population masculine au sein des familles avec mutation germinale dans les gènes BRCA1 et BRCA2 aspects cliniques et pathologiques des cancers

  2018influential citation
• Chapter 7 The BRCA 1 and BRCA 2 Breast and Ovarian Cancer Susceptibility Genes — Implications for DNA Damage Response , DNA Repair and Cancer Therapy

  2018cites this paper
• Mdm2 promotes Cdc25C protein degradation and delays cell cycle progression through the G2/M phase

  2017cites this paper
• Overexpression of TRIM44 is related to invasive potential and malignant outcomes in esophageal squamous cell carcinoma

  2017cites this paper
• UBE2T knockdown inhibits gastric cancer progression

  2017cites this paper
• The BRCA 1 and BRCA 2 Breast and Ovarian Cancer Susceptibility Genes — Implications for DNA Damage Response , DNA Repair and Cancer Therapy

  2017cites this paper
• Xanthatin triggers Chk1‐mediated DNA damage response and destabilizes Cdc25C via lysosomal degradation in lung cancer cells

  2017cites this paper
• Up-regulation of BRCA1-associated RING Domain 1 Promotes Hepatocellular Carcinoma Progression by Targeting Akt Signaling

  2017cites this paper
• Breast cancer predisposition gene brca1, pathogenic c61g mutation in mice: synthetic viability in DNA repair and tumour development

  2016influential citation
• An investigation of the role of TRIB2 in steady state and stressed haematopoiesis

  2016cites this paper
• ATM function and its relationship with ATM gene mutations in chronic lymphocytic leukemia with the recurrent deletion (11q22.3-23.2)

  2016cites this paper
• PICT-1 is a key nucleolar sensor in DNA damage response signaling that regulates apoptosis through the RPL11-MDM2-p53 pathway

  2016cites this paper
• Phosphorylated STAT5 regulates p53 expression via BRCA1/BARD1-NPM1 and MDM2

  2016cites this paper
• The ubiquitin ligase CRL2ZYG11 targets cyclin B1 for degradation in a conserved pathway that facilitates mitotic slippage

  2016cites this paper
• Expression of an Oncogenic BARD1 Splice Variant Impairs Homologous Recombination and Predicts Response to PARP-1 Inhibitor Therapy in Colon Cancer

  2016cites this paper
• Analogs of the novel phytohormone, strigolactone, trigger apoptosis and synergize with PARP inhibitors by inducing DNA damage and inhibiting DNA repair

  2016cites this paper
• Human TRIB2 Oscillates during the Cell Cycle and Promotes Ubiquitination and Degradation of CDC25C

  2016cites this paper
• Slip slidin ’ away of mitosis with CRL 2 Zyg 11

  2016cites this paper
• BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1.

  2016cites this paper
• THE EFFECT OF PIOGLITAZONE ON GENOMIC INSTABILITY IN INDUCED DIABETIC RATS

  2016cites this paper
• Tributyltin induces G2/M cell cycle arrest via NAD(+)-dependent isocitrate dehydrogenase in human embryonic carcinoma cells.

  2016cites this paper
• Slip slidin’ away of mitosis with CRL2Zyg11

  2016cites this paper
• Dysregulation of the BRCA1/long non-coding RNA NEAT1 signaling axis contributes to breast tumorigenesis

  2016cites this paper
• The BRCA1 and BRCA2 Breast and Ovarian Cancer Susceptibility Genes — Implications for DNA Damage Response, DNA Repair and Cancer Therapy

  2015cites this paper
• Genetic predisposition to breast and/or ovarian cancer – focus on the candidate BARD1 gene

  2015cites this paper
• RAD9A Stabilization and Destabilization Processes in Checkpoint Maintenance and Checkpoint Recovery

  2015influential citation
• Breast cancer cells: Modulation by melatonin and the ubiquitin-proteasome system--a review.

  2015cites this paper
• Implications of BRCA1 mutations in basal-like breast cancer development and treatment

  2015cites this paper
• BRCA1 and Oxidative Stress

  2014cites this paper
• DEVELOPMENT OF A FUNCTIONAL ASSAY FOR DETERMINATION OF BRCA1 CARRIER STATUS

  2014cites this paper
• Role of the Polyadenylation Factor CstF-50 in regulating the BRCA1/BARD1 E3 Ubiquitin (Ub) Ligase Activity

  2014cites this paper
• Cooperation between BRCA1 and vitamin D is critical for histone acetylation of the p21waf1 promoter and for growth inhibition of breast cancer cells and cancer stem-like cells

  2014cites this paper
• Cooperation between BRCA 1 and vitamin D is critical for histone acetylation of the p 21 waf 1 promoter and for growth inhibition of breast cancer cells and cancer stem-like cells

  2014cites this paper
• Suppression of BRCA1 sensitizes cells to proteasome inhibitors

  2014cites this paper
• The negative interplay between Aurora A/B and BRCA1/2 controls cancer cell growth and tumorigenesis via distinct regulation of cell cycle progression, cytokinesis, and tetraploidy

  2014cites this paper
• Opportunities and hurdles in the treatment of BRCA1-related breast cancer

  2014cites this paper
• Role of the Na ⁺/K ⁺/2Cl⁻ cotransporter NKCC1 in cell cycle progression in human esophageal squamous cell carcinoma.

  2014cites this paper
• Role of the Polyadenylation Factor CstF-50 in regulating the BRCA1/BARD1 E3 Ubiquitin (Ub) Ligase Activity

  2014cites this paper
• Purification and biochemical analysis of catalytically active human cdc25C dual specificity phosphatase.

  2013cites this paper
• The interaction between Rad9 and Tousled-like kinase 1 in the cell cycle and the DNA damage response

  2013cites this paper
• Validation of a Gene-Expression Based Assay for BRCA1 Function

  2013cites this paper
• Tousled-Like Kinase-Dependent Phosphorylation of Rad9 Plays a Role in Cell Cycle Progression and G2/M Checkpoint Exit

  2013cites this paper